Lastya Agus, Saraswati Made Ratna, Suastika Ketut
Division of Endocrinology and Metabolism, Department of Internal Medicine, Faculty of Medicine, Udayana University-Sanglah Hospital, Kamboja Street, Dangin Puri Kangin, No 8, 80233, Denpasar, Bali, Indonesia.
BMC Res Notes. 2014 Nov 26;7:849. doi: 10.1186/1756-0500-7-849.
Glucagon like peptide-1 (GLP-1), an incretin hormone, regulates glucose metabolism by inducing insulin secretion and suppressing glucagon secretion. The aim of the study is to assess the levels of fasting and post-prandial GLP-1 and their risk for T2DM. A case control study was conducted at the diabetes clinic Sanglah Hospital Denpasar Bali, involving 40 subjects who were native Indonesian citizens and 18-70 years of age. Twenty subjects were allocated as the case group (subjects with T2DM) and 20 subjects were allocated as the control group (subjects with normal glucose tolerance [NGT]). Both fasting intact GLP-1 (FGLP-1) and 60 minutes post-75 gram glucose loading intact GLP-1 (1hGLP-1) levels were measured.
Both fasting and post-prandial GLP-1 levels were significantly lower in subjects with T2DM than those with NGT (2.06 ± 0.43 vs. 2.87 ± 0.67 pg/L, p < 0.01; and 2.49 ± 0.60 vs. 3.42 ± 0.85 pg/L, p = 0.02; respectively). Low levels of FGLP-1 (OR, 13.5; p = 0.001) and 1hGLP-1 (OR, 5.667, p = 0.018), with no response after glucose loading (∆GLP-1), were a significant risk for T2DM. According to the ∆GLP-1, there was a tendency of decreasing response of GLP-1 after glucose loading among subjects with T2DM (∆ = 0.43 pg/L) compared to subjects with NGT (∆ = 0.55 pg/L).
From this study it can be concluded that levels of intact GLP-1 are an important risk factor for T2DM in the Indonesian population.
胰高血糖素样肽-1(GLP-1)是一种肠促胰岛素激素,通过诱导胰岛素分泌和抑制胰高血糖素分泌来调节葡萄糖代谢。本研究旨在评估空腹和餐后GLP-1水平及其患2型糖尿病(T2DM)的风险。在巴厘岛登巴萨桑格拉医院的糖尿病诊所进行了一项病例对照研究,纳入40名年龄在18至70岁之间的印度尼西亚本土公民。20名受试者被分配为病例组(T2DM患者),20名受试者被分配为对照组(糖耐量正常[NGT]者)。测量了空腹完整GLP-1(FGLP-1)水平以及75克葡萄糖负荷后60分钟的完整GLP-1(1hGLP-1)水平。
T2DM患者的空腹和餐后GLP-1水平均显著低于NGT者(分别为2.06±0.43 vs. 2.87±0.67 pg/L,p<0.01;以及2.49±0.60 vs. 3.42±0.85 pg/L,p=0.02)。FGLP-1水平低(比值比[OR]为13.5;p=0.001)和1hGLP-1水平低(OR为5.667,p=0.018),且葡萄糖负荷后无反应(∆GLP-1),是T2DM的显著风险因素。根据∆GLP-1,与NGT者(∆=0.55 pg/L)相比,T2DM患者葡萄糖负荷后GLP-1反应有下降趋势(∆=0.43 pg/L)。
从本研究可以得出结论,完整GLP-1水平是印度尼西亚人群患T2DM的重要风险因素。